High Concentration Nucleic Acid Liquid Composition Patent Registration Confirmed in Japan


PharmaResearch plans to apply various formulations to this patent.

PharmaResearch (CEO Kim Thinkyou, Kang Ki-seok) announced that the patent registration of high concentration nucleic acid liquid composition is confirmed in Japan. The patent is titled “liquid composition containing a high concentration of a mixture of DNA fragments and having fluidity and a method of preparing the same”. It is a technology that enhances the gelation phenomenon that occurs when dissolving nucleic acids at high concentration and is characterized by enhanced nucleic acid injection.

Through this patent strategy, PharmaResearch will be able to obtain the unique and exclusive rights to the liquid high-concentration nucleic acid composition in Japan until March 2039.

A PharmaResearch official said, “The patent confirmed that high-concentration nucleic acids can be effectively injected into the human body. It is expected that it can be applied to the development of various formulations such as injections and liquid agents using high concentration DNA fragment mixtures with fluidity.

PharmaResearch is a regenerative medicine-based pharmaceutical biotechnology company that manufactures and sells pharmaceuticals, medical devices, cosmetics and health functional foods, focusing on DOT™ PDRN and DOT™ PN tissue regeneration materials. Representative items include Rejuran®, Conjuran®, Rejuran Cosmetics and Re-An® eye drops.

Media Contact
Company Name: PharmaResearch
Contact person: Seulki Kwak
E-mail: Send an email
Call: +82-31-8039-1422
Address:77-19, Gwahakdanji-ro
City: Gangneung-si
State: Gangwon-do
Country: South Korea
Website: http://pharmaresearch.co.kr/eng

Press release distributed by ABNewswire.com

To view the original version on ABNewswire, visit: High Concentration Nucleic Acid Liquid Composition Patent Registration Confirmed in Japan

Previous Dell's New Developer-Focused Strategy: Dell World 2022
Next Eightfold AI and Deloitte Alliance Accelerate Competency-Based Talent Transformation